| Item Type | Name |
|
Concept
|
Aconitate Hydratase
|
|
Concept
|
Acute Disease
|
|
Concept
|
Actins
|
|
Concept
|
Alberta
|
|
Concept
|
Acetylation
|
|
Concept
|
Administration, Inhalation
|
|
Concept
|
Angiotensin II
|
|
Concept
|
Antimycin A
|
|
Concept
|
Aorta, Thoracic
|
|
Concept
|
Arrhythmias, Cardiac
|
|
Concept
|
Aftercare
|
|
Concept
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
|
|
Concept
|
American Heart Association
|
|
Concept
|
Amino Acid Oxidoreductases
|
|
Concept
|
Aminorex
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Ambulatory Care
|
|
Concept
|
Aerosols
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Bundle-Branch Block
|
|
Concept
|
Angiography
|
|
Concept
|
Animals
|
|
Concept
|
Animals, Newborn
|
|
Concept
|
Anticoagulants
|
|
Concept
|
Angina Pectoris
|
|
Concept
|
Aorta
|
|
Concept
|
Aminoquinolines
|
|
Concept
|
Quaternary Ammonium Compounds
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Antioxidants
|
|
Concept
|
Aortic Valve
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Arginine
|
|
Concept
|
Cyclohexanols
|
|
Concept
|
Aorta, Abdominal
|
|
Concept
|
Appetite Depressants
|
|
Concept
|
Benzamides
|
|
Concept
|
Carotid Body
|
|
Concept
|
Benzoates
|
|
Concept
|
Atropine
|
|
Concept
|
Dichloroacetic Acid
|
|
Concept
|
Digoxin
|
|
Concept
|
Dithionitrobenzoic Acid
|
|
Concept
|
Diuretics
|
|
Concept
|
Barium
|
|
Concept
|
Biopsy, Needle
|
|
Concept
|
Electrons
|
|
Concept
|
Capsid
|
|
Concept
|
Carbon Monoxide
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Cattle
|
|
Concept
|
Cell Separation
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Chelating Agents
|
|
Concept
|
Cholesterol, Dietary
|
|
Concept
|
Chemoreceptor Cells
|
|
Concept
|
Chicago
|
|
Concept
|
Bradykinin
|
|
Concept
|
Chromium
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Coronary Disease
|
|
Concept
|
Cholesterol
|
|
Concept
|
Contrast Media
|
|
Concept
|
Coronary Artery Disease
|
|
Concept
|
Diet Surveys
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Indians, North American
|
|
Concept
|
Injections, Intramuscular
|
|
Concept
|
Iron
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Disulfides
|
|
Concept
|
Cause of Death
|
|
Concept
|
Dogs
|
|
Concept
|
Deferoxamine
|
|
Concept
|
Health Surveys
|
|
Concept
|
Electrophysiology
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Long QT Syndrome
|
|
Concept
|
Delivery of Health Care
|
|
Concept
|
Diazooxonorleucine
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Mass Screening
|
|
Concept
|
Cobalt
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Electron Transport Complex IV
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
DNA
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Fishes
|
|
Concept
|
Ferrous Compounds
|
|
Concept
|
Fibrinogen
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Infant, Premature
|
|
Concept
|
Electric Conductivity
|
|
Concept
|
Environment
|
|
Concept
|
Methyltransferases
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Mitral Valve
|
|
Concept
|
Models, Chemical
|
|
Concept
|
Atrial Natriuretic Factor
|
|
Concept
|
Fasting
|
|
Concept
|
Feasibility Studies
|
|
Concept
|
Ferric Compounds
|
|
Concept
|
Fetal Heart
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Nifedipine
|
|
Concept
|
Dietary Fats, Unsaturated
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
|
Concept
|
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
|
|
Concept
|
Heart
|
|
Concept
|
Heart Ventricles
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Ductus Arteriosus
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Hyperlipoproteinemia Type II
|
|
Concept
|
Hypoglycemic Agents
|
|
Concept
|
Liposomes
|
|
Concept
|
Hospitalization
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Inflammation
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Gastroesophageal Reflux
|
|
Concept
|
Gene Amplification
|
|
Concept
|
Guanylate Cyclase
|
|
Concept
|
Headache
|
|
Concept
|
Health Services Accessibility
|
|
Concept
|
Heart Atria
|
|
Concept
|
Lipoma
|
|
Concept
|
Macrophages
|
|
Concept
|
Luminescent Measurements
|
|
Concept
|
Mammary Arteries
|
|
Concept
|
Iron-Sulfur Proteins
|
|
Concept
|
Ischemia
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Hypertension, Portal
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Mitral Valve Stenosis
|
|
Concept
|
Phosphatidylcholines
|
|
Concept
|
Phospholipids
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Myocardial Infarction
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Minnesota
|
|
Concept
|
Models, Cardiovascular
|
|
Concept
|
Nitrates
|
|
Concept
|
Nitrogen Oxides
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Meclofenamic Acid
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Organ Culture Techniques
|
|
Concept
|
Muscle, Smooth, Vascular
|
|
Concept
|
Neomycin
|
|
Concept
|
Glycogen
|
|
Concept
|
Granulomatous Disease, Chronic
|
|
Concept
|
Oxidative Phosphorylation
|
|
Concept
|
Pancreatic Elastase
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Random Allocation
|
|
Concept
|
Mitogens
|
|
Concept
|
Molecular Biology
|
|
Concept
|
Myocardial Contraction
|
|
Concept
|
Cricetinae
|
|
Concept
|
Health Policy
|
|
Concept
|
Heartburn
|
|
Concept
|
Heat-Shock Proteins
|
|
Concept
|
Ion Channels
|
|
Concept
|
Neutrophils
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Laparoscopy
|
|
Concept
|
Phagocytosis
|
|
Concept
|
Phosphodiesterase Inhibitors
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Rodentia
|
|
Concept
|
Membrane Fusion
|
|
Concept
|
Methylene Blue
|
|
Concept
|
Mitochondria, Heart
|
|
Concept
|
Practice Patterns, Physicians'
|
|
Concept
|
Phthalimides
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Oxygen
|
|
Concept
|
Patient Care Team
|
|
Concept
|
Feeding Behavior
|
|
Concept
|
Fibrosis
|
|
Concept
|
Porphyrins
|
|
Concept
|
Taste
|
|
Concept
|
Phycoerythrin
|
|
Concept
|
Potassium
|
|
Concept
|
Drug Prescriptions
|
|
Concept
|
Epoprostenol
|
|
Concept
|
Thromboembolism
|
|
Concept
|
Thymoma
|
|
Concept
|
Prostaglandins
|
|
Concept
|
Glyburide
|
|
Concept
|
Glomerular Mesangium
|
|
Concept
|
Recurrence
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Rabbits
|
|
Concept
|
Registries
|
|
Concept
|
Restaurants
|
|
Concept
|
Risk Factors
|
|
Concept
|
Vasomotor System
|
|
Concept
|
Serotonin Antagonists
|
|
Concept
|
Quality of Life
|
|
Concept
|
Somatostatin
|
|
Concept
|
Potassium Channels
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Radionuclide Angiography
|
|
Concept
|
Rats, Nude
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Sarcoidosis
|
|
Concept
|
Serotonin
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Swine
|
|
Concept
|
Sheep
|
|
Concept
|
Silver
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Humans
|
|
Concept
|
Hypercapnia
|
|
Concept
|
Hypercholesterolemia
|
|
Concept
|
Incidence
|
|
Concept
|
Linear Models
|
|
Concept
|
Single-Blind Method
|
|
Concept
|
Superoxides
|
|
Concept
|
Intracellular Membranes
|
|
Concept
|
Cardiology Service, Hospital
|
|
Concept
|
United States
|
|
Concept
|
Oxidants
|
|
Concept
|
Warfarin
|
|
Concept
|
Vasodilator Agents
|
|
Concept
|
3',5'-Cyclic-GMP Phosphodiesterases
|
|
Concept
|
Drug Design
|
|
Concept
|
Calcium Channels
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Isoquinolines
|
|
Concept
|
Hyperoxia
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Oleic Acid
|
|
Concept
|
Disease Management
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
rho GTP-Binding Proteins
|
|
Concept
|
rhoB GTP-Binding Protein
|
|
Concept
|
Uncoupling Agents
|
|
Concept
|
Models, Animal
|
|
Concept
|
Ventricular Fibrillation
|
|
Concept
|
S Phase
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Guanosine 5'-O-(3-Thiotriphosphate)
|
|
Concept
|
4-Aminopyridine
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Antigens, Differentiation, Myelomonocytic
|
|
Concept
|
Prevalence
|
|
Concept
|
G1 Phase
|
|
Concept
|
Monocrotaline
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Nisoldipine
|
|
Concept
|
Mitochondria
|
|
Concept
|
Mitochondria, Muscle
|
|
Concept
|
Infusion Pumps, Implantable
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Rats, Wistar
|
|
Concept
|
Tacrolimus
|
|
Concept
|
Myocardium
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Age Distribution
|
|
Concept
|
Methods
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
NADH Dehydrogenase
|
|
Concept
|
National Institutes of Health (U.S.)
|
|
Concept
|
Annexin A1
|
|
Concept
|
Cyclooxygenase Inhibitors
|
|
Concept
|
Tachycardia, Ventricular
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Efficiency, Organizational
|
|
Concept
|
Patch-Clamp Techniques
|
|
Concept
|
Dopamine Agonists
|
|
Concept
|
Impotence, Vasculogenic
|
|
Concept
|
Disease Progression
|
|
Concept
|
Telomerase
|
|
Concept
|
omega-N-Methylarginine
|
|
Concept
|
Cytochrome P-450 CYP2E1
|
|
Concept
|
Glucose Intolerance
|
|
Concept
|
Fluorodeoxyglucose F18
|
|
Concept
|
Simvastatin
|
|
Concept
|
Dietary Sucrose
|
|
Concept
|
Bone Morphogenetic Protein Receptors, Type II
|
|
Concept
|
Tetraethylammonium
|
|
Concept
|
Calcium Signaling
|
|
Concept
|
Natriuretic Peptide, Brain
|
|
Concept
|
Mutation, Missense
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Potassium Channel Blockers
|
|
Concept
|
Romano-Ward Syndrome
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Patient Care Management
|
|
Concept
|
Metabolome
|
|
Concept
|
Receptors, Dopamine D1
|
|
Concept
|
Sirtuin 3
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Myofibroblasts
|
|
Concept
|
Inflammasomes
|
|
Concept
|
Ontario
|
|
Concept
|
Phosphodiesterase 5 Inhibitors
|
|
Concept
|
Microdissection
|
|
Concept
|
Biomimetics
|
|
Concept
|
MAP Kinase Kinase 4
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
Microarray Analysis
|
|
Concept
|
Proteasome Endopeptidase Complex
|
|
Concept
|
Chloride Channels
|
|
Concept
|
Endothelin-1
|
|
Concept
|
COS Cells
|
|
Concept
|
Microscopy, Confocal
|
|
Concept
|
Ryanodine Receptor Calcium Release Channel
|
|
Concept
|
5' Untranslated Regions
|
|
Concept
|
Opioid Peptides
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Quality-Adjusted Life Years
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
rhoA GTP-Binding Protein
|
|
Concept
|
DNA, Intergenic
|
|
Concept
|
Potassium Channels, Inwardly Rectifying
|
|
Concept
|
Thrombospondins
|
|
Concept
|
Sirolimus
|
|
Concept
|
Myocytes, Cardiac
|
|
Concept
|
Phenyl Ethers
|
|
Concept
|
Prenatal Exposure Delayed Effects
|
|
Concept
|
Postoperative Complications
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Prostaglandins F
|
|
Concept
|
Mice
|
|
Concept
|
Prostaglandins, Synthetic
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Pyrroles
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Research Design
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Schools, Medical
|
|
Concept
|
Mechanotransduction, Cellular
|
|
Concept
|
Substance P
|
|
Concept
|
Electron Transport Complex I
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Angiogenesis Inducing Agents
|
|
Concept
|
Cytokine Receptor gp130
|
|
Concept
|
Glucose Transporter Type 1
|
|
Concept
|
Rats
|
|
Concept
|
Nitric Oxide Synthase Type II
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
PPAR alpha
|
|
Concept
|
Staphylococcus aureus
|
|
Concept
|
Dyslipidemias
|
|
Concept
|
Xanthomatosis
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Blotting, Western
|
|
Concept
|
STAT2 Transcription Factor
|
|
Concept
|
Delayed Rectifier Potassium Channels
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
CDC2 Protein Kinase
|
|
Concept
|
Thallium
|
|
Concept
|
Thyroid Neoplasms
|
|
Concept
|
Cyclosporine
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Myocardial Reperfusion Injury
|
|
Concept
|
HLA-DP alpha-Chains
|
|
Concept
|
Survival Rate
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Free Radical Scavengers
|
|
Concept
|
Magnetic Resonance Imaging, Cine
|
|
Concept
|
Telemedicine
|
|
Concept
|
DNA Methylation
|
|
Concept
|
NADPH Oxidases
|
|
Concept
|
NG-Nitroarginine Methyl Ester
|
|
Concept
|
Dietary Supplements
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Nitric Oxide Synthase
|
|
Concept
|
Gadolinium DTPA
|
|
Concept
|
Cation Transport Proteins
|
|
Concept
|
Hepatopulmonary Syndrome
|
|
Concept
|
Coronary Stenosis
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Tubulin Modulators
|
|
Concept
|
E2F1 Transcription Factor
|
|
Concept
|
Kv Channel-Interacting Proteins
|
|
Concept
|
Shal Potassium Channels
|
|
Concept
|
Nutritional Sciences
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
Ventilator-Induced Lung Injury
|
|
Concept
|
Dynamins
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Premature Birth
|
|
Concept
|
Actin-Related Protein 2-3 Complex
|
|
Concept
|
Nitric Oxide Synthase Type III
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Nicotinamide Phosphoribosyltransferase
|
|
Concept
|
rho-Associated Kinases
|
|
Concept
|
National Heart, Lung, and Blood Institute (U.S.)
|
|
Concept
|
Cyclic Nucleotide Phosphodiesterases, Type 5
|
|
Concept
|
Growth Differentiation Factor 2
|
|
Concept
|
Hypolipidemic Agents
|
|
Concept
|
Antibodies, Antinuclear
|
|
Concept
|
Coronary Artery Bypass
|
|
Concept
|
Benzenesulfonates
|
|
Concept
|
Bronchopulmonary Dysplasia
|
|
Concept
|
Calcium
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Canada
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Diastole
|
|
Concept
|
Dietary Fats
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Electron Transport
|
|
Concept
|
Fetal Hypoxia
|
|
Concept
|
Fibrinolytic Agents
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Food Preferences
|
|
Concept
|
Food, Formulated
|
|
Concept
|
Genetic Counseling
|
|
Concept
|
Gestational Age
|
|
Concept
|
Health Personnel
|
|
Concept
|
Heart Rate
|
|
Concept
|
Hernia, Diaphragmatic
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Membrane Potentials
|
|
Concept
|
Microelectrodes
|
|
Concept
|
Models, Biological
|
|
Concept
|
Muscle Relaxation
|
|
Concept
|
NADPH Dehydrogenase
|
|
Concept
|
Niacinamide
|
|
Concept
|
Norepinephrine
|
|
Concept
|
Panic
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Pyruvate Dehydrogenase Complex
|
|
Concept
|
Rats, Mutant Strains
|
|
Concept
|
Receptors, Adrenergic, beta
|
|
Concept
|
Receptors, Opioid
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Sincalide
|
|
Concept
|
Syncope
|
|
Concept
|
Systole
|
|
Concept
|
Wisconsin
|
|
Concept
|
World Health Organization
|
|
Concept
|
Hypertriglyceridemia
|
|
Concept
|
Dinoprost
|
|
Concept
|
Cytokines
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Iloprost
|
|
Concept
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
|
|
Concept
|
Nitroarginine
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Nitric Oxide Donors
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Calcium Channels, L-Type
|
|
Concept
|
Potassium Channels, Voltage-Gated
|
|
Concept
|
Potassium Channels, Calcium-Activated
|
|
Concept
|
Optic Atrophy, Autosomal Dominant
|
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Tissue Culture Techniques
|
|
Concept
|
Microscopy, Electron, Transmission
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Large-Conductance Calcium-Activated Potassium Channels
|
|
Concept
|
Kv1.5 Potassium Channel
|
|
Concept
|
Shab Potassium Channels
|
|
Concept
|
Membrane Potential, Mitochondrial
|
|
Concept
|
Atrioventricular Block
|
|
Concept
|
HLA-DP beta-Chains
|
|
Academic Article
|
Nebulized nitric oxide/nucleophile adduct reduces chronic pulmonary hypertension.
|
|
Academic Article
|
Diversity of response in vascular smooth muscle cells to changes in oxygen tension.
|
|
Academic Article
|
Ion channels in the pulmonary vasculature.
|
|
Academic Article
|
Alterations in a redox oxygen sensing mechanism in chronic hypoxia.
|
|
Academic Article
|
Redox control of oxygen sensing in the rabbit ductus arteriosus.
|
|
Academic Article
|
Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats.
|
|
Academic Article
|
GTP (gammaS) and GDP (betaS) as electron donors: new wine in old bottles.
|
|
Academic Article
|
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
|
|
Academic Article
|
Gene transfer and metabolic modulators as new therapies for pulmonary hypertension. Increasing expression and activity of potassium channels in rat and human models.
|
|
Academic Article
|
Sildenafil reverses O2 constriction of the rabbit ductus arteriosus by inhibiting type 5 phosphodiesterase and activating BK(Ca) channels.
|
|
Academic Article
|
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
|
|
Academic Article
|
Acute oxygen-sensing mechanisms.
|
|
Academic Article
|
The NO - K+ channel axis in pulmonary arterial hypertension. Activation by experimental oral therapies.
|
|
Academic Article
|
Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension.
|
|
Academic Article
|
Oxygen activates the Rho/Rho-kinase pathway and induces RhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction.
|
|
Academic Article
|
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.
|
|
Academic Article
|
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
|
|
Academic Article
|
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
|
|
Academic Article
|
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxide.
|
|
Academic Article
|
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.
|
|
Academic Article
|
Hypoxia potentiates nitric oxide synthesis and transiently increases cytosolic calcium levels in pulmonary artery endothelial cells.
|
|
Academic Article
|
Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.
|
|
Academic Article
|
Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication.
|
|
Academic Article
|
The membrane protein MiRP3 regulates Kv4.2 channels in a KChIP-dependent manner.
|
|
Academic Article
|
Exercise thallium testing in ventricular preexcitation.
|
|
Academic Article
|
Cellular and molecular basis of pulmonary arterial hypertension.
|
|
Academic Article
|
Diversity of phenotype and function of vascular smooth muscle cells.
|
|
Academic Article
|
NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise.
|
|
Academic Article
|
Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial.
|
|
Academic Article
|
Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
|
|
Academic Article
|
Cardiac tamponade mimicking tuberculous pericarditis as the initial presentation of chronic lymphocytic leukemia in a 58-year-old woman: a case report.
|
|
Academic Article
|
Epigenetic mechanisms of pulmonary hypertension.
|
|
Academic Article
|
Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
|
|
Academic Article
|
The role of redox signaling in epigenetics and cardiovascular disease.
|
|
Academic Article
|
Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension.
|
|
Academic Article
|
Abnormal angiogenesis in blood outgrowth endothelial cells derived from von Willebrand disease patients.
|
|
Academic Article
|
Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications.
|
|
Academic Article
|
Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.
|
|
Academic Article
|
Mitochondrial dynamics--mitochondrial fission and fusion in human diseases.
|
|
Academic Article
|
An official American Thoracic Society Statement: pulmonary hypertension phenotypes.
|
|
Academic Article
|
[Relevant issues in the pathology and pathobiology of pulmonary hypertension].
|
|
Academic Article
|
MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
|
|
Academic Article
|
Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.
|
|
Academic Article
|
A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus.
|
|
Academic Article
|
An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications.
|
|
Academic Article
|
Novel Mutations and Decreased Expression of the Epigenetic Regulator TET2 in Pulmonary Arterial Hypertension.
|
|
Academic Article
|
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
|
|
Academic Article
|
SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia.
|
|
Concept
|
Imatinib Mesylate
|
|
Concept
|
Sildenafil Citrate
|
|
Concept
|
Venlafaxine Hydrochloride
|
|
Concept
|
Health Equity
|
|
Concept
|
NLR Family, Pyrin Domain-Containing 3 Protein
|
|
Concept
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
|
|
Concept
|
Soluble Guanylyl Cyclase
|
|
Concept
|
Betacoronavirus
|
|
Concept
|
NADPH Oxidase 2
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferase 1
|
|
Concept
|
Mitochondrial Dynamics
|
|
Concept
|
Hernias, Diaphragmatic, Congenital
|
|
Concept
|
Calcineurin Inhibitors
|
|
Concept
|
Endothelin Receptor Antagonists
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Vascular Remodeling
|
|
Grant
|
Impaired mitochondrial fusion in pulmonary arterial hypertension
|
|
Academic Article
|
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases.
|
|
Academic Article
|
Germline and Somatic Mutations in DNA Methyltransferase 3A (DNMT3A) Predispose to Pulmonary Arterial Hypertension (PAH) in Humans and Mice: Implications for Associated PAH.
|